5 Cheap Penny Stocks to Invest In Now

2. Niagen Bioscience, Inc. (NASDAQ:NAGE)

On March 31, Niagen Bioscience, Inc. (NASDAQ:NAGE) announced a strategic partnership with OneSpaWorld to offer pharmaceutical-grade Niagen IV treatments across more than 80 medi-spa clinics onboard premium cruise ships. This marks the company’s first entry into the cruise ship channel, expanding its Niagen Plus provider network and opening a new high-margin distribution avenue. The collaboration strengthens Niagen’s global footprint and aligns with its strategy to scale its injectable offerings beyond traditional U.S.-based clinical settings.

Previously, on March 19, the company’s board authorized an expansion of its share repurchase program, increasing the total authorization from $10 million to $20 million, signaling confidence in its intrinsic value and long-term growth prospects. Additionally, on March 5, Canaccord maintained a Buy rating on Niagen Bioscience, Inc. (NASDAQ:NAGE) while lowering its price target to $13 from $14 following fourth-quarter results, noting continued strong demand in the core business and highlighting incremental upside potential from the company’s growing injectable segment.

Niagen Bioscience, Inc. (NASDAQ:NAGE), formerly known as ChromaDex Corp., is a biotechnology company focused on healthy aging and NAD+ research, with flagship products including Niagen (nicotinamide riboside) and Tru Niagen. Headquartered in Los Angeles, the company operates at the intersection of consumer health and advanced bioscience. With expanding distribution channels, shareholder-friendly capital allocation, and strong demand fundamentals, Niagen is well-positioned to capitalize on the growing longevity market, supporting a high-upside investment thesis driven by both core and emerging revenue streams.